BeiGene
ONC
#699
Rank
ยฃ21.13 B
Marketcap
ยฃ186.28
Share price
-3.18%
Change (1 day)
61.05%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeiGene (ONC)

EPS in 2024 (TTM): -ยฃ4.89

According to BeiGene 's latest financial reports the company's current EPS (TTM) is -ยฃ4.69. .

EPS history for BeiGene from 2015 to 2024

Annual EPS

Year EPS Change
2024-ยฃ4.69
2022-ยฃ14.6528.21%
2021-ยฃ11.42-19.96%
2020-ยฃ14.2720.81%
2019-ยฃ11.8131.52%
2018-ยฃ8.98417.57%
2017-ยฃ1.74-37.16%
2016-ยฃ2.76158.95%
2015-ยฃ1.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ0.75-83.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.20-95.67%๐Ÿ‡บ๐Ÿ‡ธ USA